Oragenics Inc.

News & Events

Press Releases

In The Media

1. Oragenics Completes Approximately $16.5 Million Offering

   GlobeNewswire JUL 2, 2025 4:15 PM EDT
   SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinic...
   READ ARTICLE

2. Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants

   GlobeNewswire JUL 1, 2025 8:31 AM EDT
   SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a compan...
   READ ARTICLE

3. Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

   GlobeNewswire JUN 10, 2025 8:30 AM EDT
   SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...
   READ ARTICLE

4. Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

   GlobeNewswire MAY 28, 2025 7:00 AM EDT
   SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“...
   READ ARTICLE

5. Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

   GlobeNewswire MAY 13, 2025 8:30 AM EDT
   SARASOTA, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotech...
   READ ARTICLE

6. Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision

   GlobeNewswire MAY 12, 2025 8:30 AM EDT
   SARASOTA, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotech...
   READ ARTICLE

7. Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

   GlobeNewswire APR 23, 2025 8:30 AM EDT
   SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
   READ ARTICLE

8. Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

   GlobeNewswire APR 9, 2025 8:58 AM EDT
   SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
   READ ARTICLE

9. Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

   GlobeNewswire APR 7, 2025 4:30 PM EDT
   SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
   READ ARTICLE

10. Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

    GlobeNewswire MAR 27, 2025 8:30 AM EDT
    SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE